Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew T Gillespie

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 31, 2008
Cardiotrophin-1 is an osteoclast-derived stimulus of bone formation required for normal bone remodelingEmma C Walker, Narelle E McGregor, Ingrid J Poulton, et al.
The Biochemical Journal|February 6, 2013
HSP90 inhibitors enhance differentiation and MITF (microphthalmia transcription factor) activity in osteoclast progenitorsA Gabrielle J van der Kraan, Ryan C C Chai, Preetinder P Singh, et al.
Cancer Research|June 3, 2005
The heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygeldanamycin, enhances osteoclast formation and potentiates bone metastasis of a human breast cancer cell lineJohn T Price, Julian M W Quinn, Natalie A Sims, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 3, 2009
Germline deletion of AMP-activated protein kinase beta subunits reduces bone mass without altering osteoclast differentiation or functionJulian M W Quinn, Shanna Tam, Natalie A Sims, et al.
Internal Medicine Journal|September 12, 2017
Urolithiasis is prevalent and associated with reduced bone mineral density in β-thalassaemia majorPhillip Wong, Frances Milat, Peter J Fuller, et al.
Blood|January 24, 2015
The mouse NKR-P1B:Clr-b recognition system is a negative regulator of innate immune responsesMir Munir A Rahim, Peter Chen, Amelia N Mottashed, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 17, 2008
EphrinB2 regulation by PTH and PTHrP revealed by molecular profiling in differentiating osteoblastsElizabeth H Allan, Karl D Häusler, Tao Wei, et al.
Bone|October 20, 2006
Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitroAkira Nakamura, Chi Ly, Mirijana Cipetić, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 25, 2015
RARγ is a negative regulator of osteoclastogenesisAlanna C Green, Ingrid J Poulton, Christina Vrahnas, et al.
The Journal of Clinical Investigation|January 7, 2010
Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in miceEmma C Walker, Narelle E McGregor, Ingrid J Poulton, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 31, 2008
Cardiotrophin-1 is an osteoclast-derived stimulus of bone formation required for normal bone remodelingEmma C Walker, Narelle E McGregor, Ingrid J Poulton, et al.
The Biochemical Journal|February 6, 2013
HSP90 inhibitors enhance differentiation and MITF (microphthalmia transcription factor) activity in osteoclast progenitorsA Gabrielle J van der Kraan, Ryan C C Chai, Preetinder P Singh, et al.
Cancer Research|June 3, 2005
The heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygeldanamycin, enhances osteoclast formation and potentiates bone metastasis of a human breast cancer cell lineJohn T Price, Julian M W Quinn, Natalie A Sims, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 3, 2009
Germline deletion of AMP-activated protein kinase beta subunits reduces bone mass without altering osteoclast differentiation or functionJulian M W Quinn, Shanna Tam, Natalie A Sims, et al.
Internal Medicine Journal|September 12, 2017
Urolithiasis is prevalent and associated with reduced bone mineral density in β-thalassaemia majorPhillip Wong, Frances Milat, Peter J Fuller, et al.
Blood|January 24, 2015
The mouse NKR-P1B:Clr-b recognition system is a negative regulator of innate immune responsesMir Munir A Rahim, Peter Chen, Amelia N Mottashed, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 17, 2008
EphrinB2 regulation by PTH and PTHrP revealed by molecular profiling in differentiating osteoblastsElizabeth H Allan, Karl D Häusler, Tao Wei, et al.
Bone|October 20, 2006
Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitroAkira Nakamura, Chi Ly, Mirijana Cipetić, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 25, 2015
RARγ is a negative regulator of osteoclastogenesisAlanna C Green, Ingrid J Poulton, Christina Vrahnas, et al.
The Journal of Clinical Investigation|January 7, 2010
Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in miceEmma C Walker, Narelle E McGregor, Ingrid J Poulton, et al.
Pageof 5